Clinical Trial Update: A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants [Phase 1]

View source ↗

Summary

Grünenthal GmbH completed a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of GRT6019 in healthy male participants, including an asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• GRT6019

Snippet

Sponsor: Grünenthal GmbH | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 1 | Status: COMPLETED